ArticleAnnals of surgical oncology2026
Surgical Challenges Associated with Collateral Veins Formation in Pancreatic Cancer with Vein Resection.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdvanced pancreatic ductal adenocarcinoma (PDAC) often infiltrates or obstructs the superior mesenteric vein (SMV)/portal vein, leading to collateral vein (CV) formation. Although CVs are hypothesized to affect surgical outcomes, data regarding their clinical significance remain limited. This study aimed to evaluate the impact of CV formation on short-term outcomes in patients with PDAC who underwent portomesenteric venous resection (PVR).
methodsWe retrospectively analyzed PDAC cases undergoing PVR at our institution between 2010 and 2023. CVs were identified using preoperative computed tomography, and patients were categorized based on the presence or absence of CVs. Short-term outcomes were assessed prospectively. A subgroup analysis was performed to evaluate the clinical relevance of proximal versus distal SMV involvement.
resultsAmong 403 patients with PDAC undergoing PVR, 27 (6.7%) had CVs. The CV group exhibited significantly longer operative times (median: 618 vs. 517 minutes, p < 0.0001) and greater blood loss (median: 1500 vs. 590 mL, p < 0.0001). Postoperative complications (Clavien-Dindo classification ≥IIIa) were more frequent in the CV group (33.3% vs. 10.1%, p = 0.002). Multivariate analysis identified CV formation as the strongest predictor of blood loss ≥1000 mL (odds ratio: 6.63 [95% confidence interval 2.70-17.3], p < 0.0001). As expected, distal SMV involvement correlated with longer operative times but did not impact other outcomes.
conclusionsCV formation, a characteristic feature of advanced PDAC, was strongly associated with increased surgical difficulty and postoperative complications, highlighting the need for tailored strategies to optimize outcomes in PDAC cases undergoing PVR.
Indexed as
Identifiers
41379259What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.